SEC Company Response from GENOMIC HEALTH INC (CIK 0001131324) — Sep 26, 2005
GENOMIC HEALTH INC (CIK 0001131324)
Date: Sept. 26, 2005 · CIK: 0001131324 · Accession: 0000891618-05-000750
AI Filing Summary & Sentiment
File numbers found in text: 333-126626
Letter
Genomic Health, Inc.
301 Penobscot Drive
Redwood City, California 94063
September 26, 2005
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Genomic Health, Inc.
Registration Statement — Form S-1 (File No. 333-126626)
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Genomic Health, Inc. (the “Registrant”) hereby requests that the Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1, relating to the registration of 5,769,230 shares of the Registrant’s Common Stock, to become effective at 4:00 p.m. (Eastern Daylight Time) on September 28, 2005, or as soon thereafter as possible.
GENOMIC HEALTH, INC.
By: /s/ G. Bradley Cole
G. Bradley Cole,
Executive Vice President and CFO
cc:
G.A. Lombardi
J.D. Hovey
Show Raw Text
CORRESP
1
filename1.htm
corresp
Genomic Health, Inc.
301 Penobscot Drive
Redwood City, California 94063
September 26, 2005
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Genomic Health, Inc.
Registration Statement — Form S-1 (File No. 333-126626)
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Genomic Health, Inc. (the
“Registrant”) hereby requests that the Commission take appropriate action to cause the
above-referenced Registration Statement on Form S-1, relating to the registration of 5,769,230
shares of the Registrant’s Common Stock, to become effective at 4:00 p.m. (Eastern Daylight Time)
on September 28, 2005, or as soon thereafter as possible.
GENOMIC HEALTH, INC.
By:
/s/ G. Bradley Cole
G. Bradley Cole,
Executive Vice President and CFO
cc:
G.A. Lombardi
J.D. Hovey